Does Adjuvant Therapy Benefit Low-Risk Resectable Cholangiocarcinoma? An Evaluation of the NCCN Guidelines

Munir, MM; Ruff, SM; Endo, Y; Lima, HA; Alaimo, L; Moazzam, Z; Shaikh, C; Pawlik, TM

Pawlik, TM (通讯作者)，Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA.;Pawlik, TM (通讯作者)，James Comprehens Canc Ctr, Columbus, OH 43210 USA.

JOURNAL OF GASTROINTESTINAL SURGERY, 2023; 27 (3): 511

Abstract

Background The National Comprehensive Cancer Network (NCCN) guidelines recommend adjuvant therapy for patients with resectable cholangiocarcinoma (CCA......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索